- Home
- NVO vs MUFG Comparison
NVO vs MUFG Comparison
Compare NVO & MUFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NVO | MUFG |
|---|---|---|
| Founded | 1923 | 1880 |
| Country | Denmark | Japan |
| Employees | 69500 | 178953 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 172.5B | 188.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NVO | MUFG |
|---|---|---|
| Price | $36.53 | $17.61 |
| Analyst Decision | Hold | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $51.00 | N/A |
| AVG Volume (30 Days) | ★ 14.0M | 3.9M |
| Earning Date | 05-06-2026 | 05-14-2026 |
| Dividend Yield | ★ 3.48% | 2.32% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $3.25 |
| Revenue Next Year | $3.30 | $9.79 |
| P/E Ratio | ★ $13.60 | $25.47 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $35.12 | $10.66 |
| 52 Week High | $81.44 | $20.15 |
Technical Indicators
Market Signals| Indicator | NVO | MUFG |
|---|---|---|
| Relative Strength Index (RSI) | 38.52 | 54.86 |
| Support Level | $35.85 | $14.80 |
| Resistance Level | $37.44 | $17.79 |
| Average True Range (ATR) | 0.94 | 0.37 |
| MACD | 0.45 | 0.16 |
| Stochastic Oscillator | 36.87 | 80.72 |
Price Performance
Historical ComparisonAbout NVO Novo Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About MUFG Mitsubishi UFJ Financial Group Inc.
Mitsubishi UFJ Financial Group is the largest bank in Japan in terms of market capitalization and assets, with an 8.4% share of all domestic loans as of March 2025. It is the largest non-Chinese bank group globally and has a balance sheet slightly larger than those of JPMorgan Chase and HSBC Holdings. MUFG's operations in Japan account for around half of profit, banking in Thailand and Indonesia for around 15%, and equity-method earnings from Morgan Stanley most of the rest.